Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
71%(5 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_1
3
33%
Ph phase_4
3
33%

Phase Distribution

3

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 4Post-market surveillance
3(33.3%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(7)
Terminated(2)

Detailed Status

Completed7
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (33.3%)
Phase 43 (33.3%)
N/A3 (33.3%)

Trials by Status

completed778%
terminated111%
withdrawn111%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_1

Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin

NCT02266329
completedphase_4

Reducing Cannabis Overuse With Prazosin

NCT04721353
terminatedphase_4

Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI)

NCT03221751
completednot_applicable

Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD

NCT02226367
completedphase_1

The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot Study

NCT01999530
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT02266329Phase 1

Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin

Completed
NCT04721353Phase 4

Reducing Cannabis Overuse With Prazosin

Completed
NCT03221751Phase 4

Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI)

Terminated
NCT02226367Not Applicable

Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD

Completed
NCT01999530Phase 1

The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot Study

Completed
NCT00487032Phase 4

Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation

Completed
NCT00990106Not Applicable

Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)

Completed
NCT00223717Phase 1

Treatment of Supine Hypertension in Autonomic Failure

Completed
NCT00890643Not Applicable

Effect of Prazosin on Neurophysiology and Cognition in Post-Traumatic Stress Disorder (PTSD)

Withdrawn

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9